Recurrent urinary tract infections in women

Current Women's Health Reports

Volumn 3, Issue 4, 2003, Pages 313-318

  Sotelo, Tiffany ^a   Westney, O Lenaine ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFALOTIN; CIPROFLOXACIN; COTRIMOXAZOLE; ESTRIOL; ESTROGEN; FLEROXACIN; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VACCINE; ANTIINFECTIVE AGENT; URINARY TRACT ANTIINFECTIVE AGENT;

BACTERIUM CULTURE; CELL SURFACE; CLINICAL TRIAL; COST OF ILLNESS; CRANBERRY; EMOTIONALITY; HEALTH CARE COST; HOST RESISTANCE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MENOPAUSAL SYNDROME; PATHOGENESIS; RECURRENT INFECTION; REVIEW; URINARY TRACT INFECTION; URINE CULTURE; CLASSIFICATION; FEMALE; NOMENCLATURE; RECURRENT DISEASE; RISK FACTOR; UNITED STATES; WOMEN'S HEALTH;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; FEMALE; HUMANS; RECURRENCE; RISK FACTORS; TERMINOLOGY; UNITED STATES; URINARY TRACT INFECTIONS; WOMEN'S HEALTH;

EID: 0141609661     PISSN: 15345874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Foxman B: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl 1A):5S-13S.
2. Kunin CM: Urinary tract infections in females. Clin Infect Dis 1994, 18:1-12.
3. Ronald AR: Sexually transmitted diseases and urinary tract infections. Curr Opin Infect Dis 1995, 8:1-3.
4. Stamm WE, Counts GW, Running KR, et al.: Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982, 307:463-468.
5. Hooten TM: Epidemiology. In Urinary Tract Infection in the Female. Edited by Stanton SL, Dwyer PL. London: Martin Dunitz; 2000:2-14.
6. Corriere JN: Avoiding "overkill" in diagnosis and treatment of lower urinary tract infections. Urology 1988, 32(Suppl 2):17-21.
7. Engel JD, Schaeffer AJ: Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am 1998, 25:685-701.
8. Stamey TA: Pathogenesis and Treatment of Urinary Tract Infections. Baltimore: Williams and Wilkins; 1980.
9. Schaeffer AJ: Infections of the urinary tract. In Campbell's Urology, edn 8. Edited by Walsh PC, Retik AB, Vaughan ED, et al. Philadelphia: WB Saunders; 2002:515-602.
10. Hooten TM: Recurrent urinary tract infections in women. Intl Antimicrob Agents 2001, 17:259-268.
11. Vosti KL: Infections of the urinary tract in women. Medicine 2002, 81:369-387.
12. Stamey TA, Sexton CC: The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infection. J Urol 1975, 113:214-217.
13. Schaeffer AJ, Jones DM, Dunn JK: Association of in vitro Escherchia coli adherence to vaginal and buccal epithelial cells from women with recurrent urinary tract infection. Infection 1982, 10:186-191.
14. Hopkins WJ, Ueling DT, Wargowski DS: Evaluation of a familial predisposition to recurrent urinary tract infections in women. Am J Med Genet 1999, 83:422-424.
15. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al.: Association of the Lewis Blood-Group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989, 320:773-777.
16. Stapleton AJ, Nudelman E, Clausen H, et al.: Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histoblood group secretor status. J Clin Invest 1992,90:965-72.
17. Stapleton A, Hooton TM, Fennell C, et al.: Effect of secretor status on vaginal and rectal colonization with fimbriated Escherichia coli in women with and without recurrent urinary tract infection. J Infect Dis 1995, 171:717-720.
18. Krcméry S, Hromec J, Tvrdikova M, et al.: Newer quinolones in the long-term prophylaxis of recurrent urinary tract infections. Drugs 1999 58(Suppl 2):99-102.
19. Scholes D, Hooton TM, Roberts PL, et al.: Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000, 182:1177-1182.
20. Gupta K, Hillier SL, Hooton TM, et al.: Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infec Dis 2000, 181:595-601.
21. Eckford SD, Keane DP, Lamond E, et al.: Hydration monitoring in the prevention of recurrent idiopathic urinary tract infections in pre-menopausal women. Br J Urol 1995, 76:90-93.
22. Raz R, Gennesin Y, Wasser J, et al.: Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000, 30:152-156.
23. Gomolin I, McCue J: Urinary tract infection in the elderly patient. Infect Urol 2000, 13:S7-S13.
24. Hooton TM, Stapleton AE, Roberts PL, et al.: Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infection. Clin Infec Dis 1999, 29:1600-1601.
25. van Haarst EP, van Andel G, Heldeweg EA, et al.: Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections. Urology 2001, 57:1068-1072.
26. Lachs MS, Nachamkin I, Edelstein PH, et al.: Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med 1992, 117:135-140.
27. Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997, 11:551-581.
28. Norrby SR: Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990, 12:458-467.
29. Raz R, Rozenfeld S: 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women. Antimicrob Agents Chemother 1996, 40:2200-2201.
30. McCarty JM, Richard G, Huck W, et al.: A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999, 106:292-299.
31. Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999, 281:736-738.
32. Warren JW, Abrutyn E, Hebel JR, et al.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infec Dis 1999, 29:745-758.
33. Brumfitt W, Hamilton-Miller JMT: Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother 1998, 42:363-371.
34. Vahlensieck W Jr, Westenfelder M: Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. Int Urol Nephrol 1992, 24:3-10.
35. Schaeffer AJ, Stuppy BA: Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999, 161:207-211.
36. Uehling DT, Hopkins WJ, Beierle LM, et al.: Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis 2001, 183(Suppl 1):S81-S83.
37. Stephenson J: Experimental vaccine for recurrent UTIs. JAMA 2002, 287:702-703.
38. Melekos MD, Asbach HW, Gerharz E, et al.: Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997, 157:935-939.
39. Raz R: Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 2001, 183(Suppl 1):S74-S76.
40. Raz R, Stamm WA: Controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993, 180:1072-1079.
41. Eriksen BC: A randomized, open, parallel-group study on the preventative effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999, 180:1072-1079.
42. Avorn J, Monane M, Gurwitz JH, et al.: Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994, 271:751-754.
43. Stothers L: A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002, 9:1558-1562.